MARKET

NRXPW

NRXPW

Nrx Pharmaceuticals Inc
NASDAQ
0.0675
-0.0065
-8.78%
Closed 15:21 12/30 EST
OPEN
0.0626
PREV CLOSE
0.0740
HIGH
0.0798
LOW
0.0534
VOLUME
26.09K
TURNOVER
--
52 WEEK HIGH
0.5000
52 WEEK LOW
0.0401
MARKET CAP
--
P/E (TTM)
-0.0291
1D
5D
1M
3M
1Y
5Y
1D
NRX Pharmaceuticals Eliminates All Debt Through Equity Conversion
Reuters · 1d ago
Weekly Report: what happened at NRXPW last week (1222-1226)?
Weekly Report · 1d ago
Weekly Report: what happened at NRXPW last week (1215-1219)?
Weekly Report · 12/22 09:28
NRX Pharmaceuticals Eliminates Remaining $5.4 Million Debt Through Equity Conversion, Achieves Debt-Free Balance Sheet
Reuters · 12/18 12:05
Weekly Report: what happened at NRXPW last week (1208-1212)?
Weekly Report · 12/15 09:30
Weekly Report: what happened at NRXPW last week (1201-1205)?
Weekly Report · 12/08 09:30
NRX PHARMACEUTICALS INC - AMENDS IND FILING FOR NRX-101 TO INCLUDE TMS USE
Reuters · 12/03 12:04
NRX PHARMACEUTICALS INC - APPLIES FOR KETAFREE AS PROPRIETARY PRODUCT NAME
Reuters · 12/02 13:30
More
About NRXPW
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). The Company has two lead compounds, NRX-100, a proprietary presentation of ketamine and NRX-101, a fixed-dose combination of D-cycloserine (DCS) and lurasidone. The Company is developing NRX-101, a Food and Drug Administration (FDA)-designated investigational therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRX-101 is a combined NMDA/5-HT2A-targeted medicine designed to address both depression and suicidal ideation, consisting of an oral, fixed dose combination of DCS and lurasidone. Its NRX-100 is racemic ketamine, which is a generic anesthetic. The Company is also engaged in the development of its new product, NRX-102.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXPW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXPW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXPW stock methods without spending real money on the virtual paper trading platform.